Satwant Reddy

Rediff.com » News » Satwant Reddy

News for Satwant Reddy

Business

Drug-trial data issue invites pharma fire

The controversial issue of exclusivity of drug-trial data -- which saw overseas multinational companies and Indian pharma companies taking opposite positions -- is back on the table. A Delhi-based......

Prices of 1,000 pharma brands to crash

The prices of close to 1,000 brands of 'generic-generic' and 'branded generic' drugs, including Omeprazole and Ciprofloxacin, are set to crash by up to 92 per cent with the pharma industry agreeing......

Drug prices to fall by 50-60%

In a move that could bring down prices of most drugs by 50-60 per cent, the pharmaceutical industry on Thursday agreed to cap the trade margin on unbranded generic drugs from October 2 this year.......

Panel on bulk drug imports from China soon

The ministry of chemicals and fertilisers is setting up a committee in two weeks to look into the import of bulk drugs from China. The panel will study the damage caused to the country's production......

Excise duty on drugs likely to be halved

The Indian pharmaceutical industry that is forking out an excise duty of 16% at present, may get some solace in the near future. The government is considering slashing the duty to 8% in the wake of......

Rediff News

Satwant Reddy

News for Satwant Reddy

Drug-trial data issue invites pharma fire

Prices of 1,000 pharma brands to crash

Drug prices to fall by 50-60%

Panel on bulk drug imports from China soon

Excise duty on drugs likely to be halved

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS